Concomitant use of antioxidants may decrease the efficacy of cisplatin in cancer patients.
Purnak
Tugrul
T
Cengiz
Mustafa
M
Altundag
Kadri
K
D000975:Antioxidants / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D003432:Cross-Linking Reagents / Q000627:therapeutic use*; D004249:DNA Damage; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy*
D000975:Antioxidants; D003432:Cross-Linking Reagents; D002945:Cisplatin